2024-518696-65-00CompletedPhase 1
A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Oct 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 16 May 2025
- Start date
- 12 Aug 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-518696-65-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 9
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.